Upgrade to SI Premium - Free Trial

Deutsche Bank stays Buy rated on Gilead Sciences (GILD) amid weekly scripts

March 27, 2026 11:27 AM
Deutsche Bank analyst James Shin reiterated a Buy rating and $155.00 price target on Gilead Sciences (NASDAQ: GILD)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments